2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Prostatic Neoplasms
13
Breast Neoplasms
13
Obesity
8
Colorectal Neoplasms
8
Ovarian Neoplasms
6
Motor Activity
5
Malnutrition
5
Rectal Neoplasms
4
Polycystic Ovary Syndrome
4
Pancreatic Neoplasms
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Radiation Injuries
3
Overweight
3
Multiple Myeloma
3
Melanoma
3
Lung Neoplasms
3
Gastrointestinal Neoplasms
3
Colonic Neoplasms
3
Weight Loss
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Insulin Resistance
2
Head and Neck Neoplasms
2
Interventions
Temozolomide
159
Bevacizumab
69
Radiotherapy
68
Magnetic Resonance Spectroscopy
68
Irinotecan
31
Surgical Procedures, Operative
27
Radiation
24
Carboplatin
23
Specimen Handling
20
Carmustine
20
Blood Specimen Collection
20
Nivolumab
19
Aminolevulinic Acid
18
Biopsy
17
Lomustine
16
pembrolizumab
13
Radiotherapy, Intensity-Modulated
13
Cyclophosphamide
13
trametinib
12
fluorodopa F 18
12
X-Rays
12
Radiosurgery
12
Erlotinib Hydrochloride
12
Topotecan
11
Everolimus
11
Magnetic Resonance Imaging
10
IL13-PE38
10
dabrafenib
9
Etoposide
9
Drug Therapy
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Glioma
×
Diet Therapy
×
Clear all
NCT02286167
2026-03-24
GLAD
Wake Forest University Health Sciences
Phase NA
Completed
25 enrolled